Team:Paris/July 22
From 2008.igem.org
(Difference between revisions)
(→Culture of Stable strain with biobricks 2008 (in 6ml LB with adaptated antibiotics)) |
(→Culture (in 6ml LB with adaptated antibiotics)) |
||
(5 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
{{Paris/Calendar_Links|July 21|July 23}} | {{Paris/Calendar_Links|July 21|July 23}} | ||
- | ==''' | + | =='''Cultures''' (in 6ml LB with adaptated antibiotics)== |
- | Culture will be use for Miniprep and Stock in glycerol | + | Culture of '''Stable strain with biobricks 2008''': |
+ | |||
+ | * will be use for Miniprep and Stock in glycerol | ||
+ | * 2 clones isolated by Biobricks : | ||
Line 10: | Line 13: | ||
|align="center"|'''Name''' | |align="center"|'''Name''' | ||
|align="center"|'''Biobricks''' | |align="center"|'''Biobricks''' | ||
+ | |align="center"|'''Description''' | ||
|align="center"|'''Antibio''' | |align="center"|'''Antibio''' | ||
|- | |- | ||
|align="center"|B0034 | |align="center"|B0034 | ||
- | |align="center"|[[Part_icon_rbs.png]] | + | |align="center"|[[Image:Part_icon_rbs.png]] |
+ | |align="center"|RBS | ||
|align="center"|A | |align="center"|A | ||
|- | |- | ||
|align="center"|C0040 | |align="center"|C0040 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Icon_coding.png]] |
+ | |align="center"|tetR repressor | ||
|align="center"|A | |align="center"|A | ||
|- | |- | ||
|align="center"|C0079 | |align="center"|C0079 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Icon_coding.png]] |
+ | |align="center"|lasR activator | ||
|align="center"|K | |align="center"|K | ||
|- | |- | ||
|align="center"|C0179 | |align="center"|C0179 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Icon_coding.png]] |
+ | |align="center"|lasR activator | ||
|align="center"|A | |align="center"|A | ||
|- | |- | ||
|align="center"|E0030 | |align="center"|E0030 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Part_icon_reporter.png]] |
+ | |align="center"|YFP | ||
|align="center"|K | |align="center"|K | ||
|- | |- | ||
|align="center"|E0040 | |align="center"|E0040 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Part_icon_reporter.png]] |
+ | |align="center"|GFP | ||
|align="center"|A | |align="center"|A | ||
|- | |- | ||
|align="center"|E1010 | |align="center"|E1010 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Part_icon_reporter.png]] |
+ | |align="center"|mRFP | ||
|align="center"|K | |align="center"|K | ||
|- | |- | ||
|align="center"|J23101 | |align="center"|J23101 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Part_icon_regulatory.png]] |
+ | |align="center"|constitutive promoter member family | ||
|align="center"|A | |align="center"|A | ||
|- | |- | ||
|align="center"|J23109 | |align="center"|J23109 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Part_icon_regulatory.png]] |
+ | |align="center"|constitutive promoter member family | ||
|align="center"|A | |align="center"|A | ||
|- | |- | ||
|align="center"|R0040 | |align="center"|R0040 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Part_icon_regulatory.png]] |
+ | |align="center"|tetR repressible promoter | ||
|align="center"|A | |align="center"|A | ||
|- | |- | ||
|align="center"|R0079 | |align="center"|R0079 | ||
- | |align="center"|[[ | + | |align="center"|[[Image:Part_icon_regulatory.png]] |
+ | |align="center"|promoter (lasr & PAI regulated) | ||
+ | |align="center"|A | ||
+ | |- | ||
+ | |align="center"|pSB1A3 | ||
+ | |align="center"|[[Image:Icon_plasmid.png]] | ||
+ | |align="center"|plasmid | ||
+ | |align="center"|A | ||
+ | |- | ||
+ | |align="center"|SO3154 | ||
+ | |align="center"|[[Image:Part_icon_rbs.png]][[Image:Icon_coding.png]] | ||
+ | |align="center"|construction intermediate | ||
+ | |align="center"|A | ||
+ | |- | ||
+ | |align="center"|S03879 | ||
+ | |align="center"|[[Image:Part_icon_rbs.png]][[Image:Icon_coding.png]] | ||
+ | |align="center"|construction intermediate | ||
|align="center"|A | |align="center"|A | ||
- | |||
- | |||
|} | |} | ||
- | |||
- | |||
- | |||
- |
Latest revision as of 15:13, 22 July 2008
Cultures (in 6ml LB with adaptated antibiotics)Culture of Stable strain with biobricks 2008:
|